Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 119737
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119737
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119737
Table 1 Details of the studies included in this meta-analysis
| Ref. | Number of patients | Intervention | Control | Study type | |
| Dexmedetomidine | Control | ||||
| Fayed et al[9], 2016 | 20 | 20 | A continuous intraoperative infusion of dexmedetomidine was administered at a rate of 0.8 µg/kg/hour, initiated following the induction of anesthesia and maintained throughout the surgical procedure until its completion | Placebo | RCT |
| Zhang et al[11], 2021 | 28 | 26 | Dexmedetomidine was administered as a continuous infusion at a rate of 0.4 µg/kg/hour, commencing at the time of surgical incision and continued until completion of the operative procedure | None | Cohort study |
| Zhang et al[12], 2022 | 62 | 59 | Dexmedetomidine was administered as a continuous intraoperative infusion at a rate of 0.4 µg/kg/hour without a loading dose, beginning at the time of surgical incision and maintained until completion of the procedure | None | Cohort study |
| Yang et al[10], 2024 | 165 | 165 | After induction of anesthesia, a loading dose of dexmedetomidine (1 μg/kg) was administered over 10 minutes, followed by a continuous infusion at 0.5 μg/kg/hour maintained throughout the surgical procedure until its completion | An equivalent volume loading dose of 0.9% saline was administered following induction of anesthesia, followed by a continuous infusion of an equal volume maintained until completion of the surgical procedure | RCT |
Table 2 Risk-of-bias summary
| Ref. | Randomization | Deviations | Missing data | Outcome measurement | Selective reporting | Overall |
| Fayed et al[9], 2016 | Unclear risk | Low risk | Low risk | Some concerns | Low risk | Some concerns |
| Yang et al[10], 2024 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Zhang et al[11], 2021 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Moderate risk |
| Zhang et al[12], 2022 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Not applicable1 | Moderate risk |
- Citation: Kulsum S, Khan SA, Dahiya DS, Ali H, Hayat U, Khalaf M, Ali H. Impact of dexmedetomidine administration on serum creatinine levels following liver transplantation: A systematic review and meta-analysis. World J Transplant 2026; 16(2): 119737
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/119737.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.119737